Related Experiment Video
Updated: Feb 8, 2026

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
Angioimmunoblastic T-cell lymphoma: a prognostic model from a retrospective study
Huangming Hong1, Xiaojie Fang1, Zhao Wang1
1a Department of Medical Oncology, Sun Yat-sen University Cancer Center , State Key Laboratory of Oncology in Southern China, and Collaborative Innovation Center of Cancer Medicine , Guangzhou , China.
A new prognostic model for Angioimmunoblastic T-cell lymphoma (AITL) effectively stratifies patients into distinct risk groups. This model improves survival prediction compared to existing methods for AITL patients.
Area of Science:
- Hematology
- Oncology
- Clinical Pathology
Background:
- Angioimmunoblastic T-cell lymphoma (AITL) is a specific subtype of peripheral T-cell lymphoma.
- AITL presents unique clinical and pathological characteristics.
- Accurate prognostic assessment is crucial for managing AITL patients.
Purpose of the Study:
- To develop and validate a novel prognostic model tailored for AITL.
- To establish a risk stratification system for AITL patients based on identified prognostic factors.
- To compare the predictive performance of the new model against established indices like the International Prognostic Index (IPI).
Main Methods:
- Retrospective analysis of 115 newly diagnosed AITL patients.
- Multivariate analysis to identify significant prognostic factors for overall survival (OS).
- Development of a three-tiered risk group system (Group 1, 2, and 3) based on the number of adverse factors.
Main Results:
- The overall five-year OS rate for the cohort was 45.4%.
- Key prognostic factors identified were bone marrow involvement, more than one extranodal site, and performance status >1.
- Five-year OS rates for risk groups were: Group 1 (no adverse factors) - 86.9%, Group 2 (one factor) - 46.3%, and Group 3 (two or three factors) - 16.2% (p < .0001).
Conclusions:
- The developed prognostic model effectively stratifies AITL patients into distinct risk categories.
- The novel model demonstrates superior predictive discrimination for survival in AITL compared to the IPI and Prognostic Index for PTCL.
- This model offers a valuable tool for personalized risk assessment and treatment planning in AITL.
Related Concept Videos
Typical Model Studies
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Case Studies
Molecular Models
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Longitudinal Studies

